← 返回事件
持续讨论商业

Johnson & Johnson is raising its full-year profit forecast as drug sales outpace devices

图:Quartz

发生了什么

The health care giant now expects adjusted EPS of $11.05 to $11.15 for 2026, and is leaning toward spinning off its orthopedics unit

摘要按规则整理自下方来源原文

来源